Stereotaxis STXS
NYSE STXS
$1.30 -0.02 (-1.52%)
As of: Sep 10, 2026 · 3:59 PM EDT

Stereotaxis (STXS) Notes Payables (2020 - 2021)

Stereotaxis' (STXS) quarterly Notes Payables came in at $1.9 million in Q1 2021, up 61.57% quarter-over-quarter from $1.2 million in Q4 2020.

Analysis

Stereotaxis (STXS) Notes Payables (2020 - 2021) Analysis & Trends

Stereotaxis (STXS) has reported Notes Payables for 2 consecutive years, with $1.9 million the latest figure, recorded in Q1 2021.

  • On a quarterly basis, Notes Payables changed N/A year-over-year to $1.9 million in Q1 2021; TTM through Mar 2021 was $1.9 million, a N/A change from a year earlier, with the FY2020 full-year figure at $1.2 million, changed N/A from the prior year.
  • Notes Payables was $1.9 million for Q1 2021 at Stereotaxis, up from $1.2 million in the prior quarter.
  • Over five years, Notes Payables peaked at $2.2 million in Q2 2020 and troughed at $457244.0 in Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn
10 Stereotaxis 129.55 Mn 114.93 Mn 3.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 1.91 Mn
Dec 31, 2020 1.19 Mn
Sep 30, 2020 457,244.00
Jun 30, 2020 2.16 Mn